Abstract: Three new polyketides, woodylides A-C (1-3), were isolated from the ethanol extract of the South China Sea sponge Plakortis simplex. The structures were elucidated by spectroscopic data (IR, 1D and 2D NMR, and HRESIMS). The absolute configurations at C-3 of 1 and 3 were determined by the modified Mosher's method. Antifungal, cytotoxic, and PTP1B inhibitory activities of these polyketides were evaluated. Compounds 1 and 3 showed antifungal activity against fungi Cryptococcus neoformans with IC 50 values of 3.67 and 10.85 µg/mL, respectively. In the cytotoxicity test, compound 1 exhibited a moderate effect against the HeLa cell line with an IC 50 value of 11.2 µg/mL, and compound 3 showed cytotoxic activity against the HCT-116 human colon tumor cell line and PTP1B inhibitory activity with IC 50 values of 9.4 and 4.7 µg/mL, respectively.
Marine sponges provide a wide range of polyketides with antibacterial [4] , antiviral [5] , antitumor [6] , antimalarial [7] , and taxol-like microtubule-stabilizing activities [8] . The sponge-derived polyketides often contain cyclic peroxides and lactone functionalities, linear and bicyclic carbon frameworks [1, 9] , and macrolide and aromatic groups in some cases [8, 10] . A prolific source of new and bioactive polyketides derived from sponges of the genus Plakortis attracted our attention. As part of our ongoing search for new pharmacologically active lead compounds from the marine sponges collected off Xisha Islands in the South China Sea [11, 12] , we investigated polyketides from the marine sponge Plakortis simplex. A preliminary study led to the isolation of two new polyketides named simplextones A and B with an unusual cyclopentane skeleton [6] . The interesting chemical and bioactive significance of P. simplex prompted us to continue the study of this sponge, which has led to the isolation of three new linear polyketides, named as woodylide A (1), B (2) and C (3) (Figure 1 ) [13] , which are the acyclic diol analogues of the cyclic polyketide peroxides isolated from the genus of Plakortis [14, 15] . This article describes the isolation, identification and bioactivity of the new compounds. 
Results and Discussion
Compound 1 was obtained as a colorless oil. Figure 2 ). The HMBC correlation from H 3 -18 (δ H 3.71) to C-1 (δ C 173.6) positioned the methoxyl group at C-1. The olefinic proton H-5 (δ H 5.11) afforded HMBC correlations to C-3 (δ C 68.8), C-4 (δ C 140.5), and C-6 (δ C 77.0), whereas H-7a (δ H 1.34) showed HMBC correlations to C-5 (δ C 132.4) and C-6, which established the connectivity of the partial structure C-3 to C-7 (δ C 48.9). Obviously, the double bond was located between C-4 and C-5 on the linear carbon scaffold based on the carbon resonances of C-4 and C-5. Accordingly, the methyl acetate group was tethered to C-4 via C-3 by HMBC correlations from H-2b (δ H 2.92) to C-1 and C-4, from H 2 -13 (δ H 2.02) to C-3, and from H-5 to C-3. The HMBC correlations from H 3 -14 (δ H 1.05) to C-4, and from H 3 -16 (δ H 0.88) to C-6, unambiguously assigned the ethyl groups to C-4 and C-6, respectively. Moreover, the HMBC correlations from H 3 -17 (δ H 0.98) to C-7 and C-9 (δ C 38.5), and from H-7b (δ H 1.55) to C-9 demonstrated the linkage of C-7, C-9 and C-17 (δ C 22.2) via C-8. Even though no COSY correlation was observed between H 2 -10 (δ H 1.25) and H 2 -11 (δ H 1.25), the connectivity of the partial structure C-9 to C-12 (δ C 14.2) was secured by the HMBC correlations of H-9b (δ H 1.30)/C-10 (δ C 29.4), and H 3 -12 (δ H 0.88)/C-10, and by comparison of the NMR date with the known derivatives [17] . With this assignment secured, the final methine (C-3) and the oxygenated quaternary carbon (C-6) had to be substituted with hydroxyl groups to satisfy the molecular formula and shifts. Table 1 ). The overall appearance of the NMR spectrum showed close structural similarity between 3 and 1, except for the absence of a methoxyl resonance in 3 instead of H 3 -18 (δ H 3.71)/C-18 (δ C 51.8) in 1, indicating 3 was a free carboxylic acid. This was also confirmed by the observation of a Δδ ~3 downfield shift of the C-1 from δ C 173.6 to δ C 176.4. The NOESY correlations observed between H 2 -13 (δ H 2.02) and H-5 (δ H 5.05), confirmed the Z geometry of the double bond at C-4 (δ C 140.9)/C-5 (δ C 131.3). The absolute configuration of C-3 was determined by the modified Mosher's method [18] . Analysis of the Δδ S−R values (Figure 3) according to Mosher's model pointed to an S-configuration for C-3 in 3.
To confirm if compound 1 could be an artifact formed from 3 during the isolation processes, a solution of 3 was kept at room temperature for three days in the presence of Si-60 or RP-18 gel in MeOH, respectively. The formation of 1 was not observed, thus suggesting that compound 1 may be a natural product and not an artifact.
The three new polyketides 1-3 were evaluated for antifungal activity against Cryptococcus neoformans (ATCC 90113), Candida albicans (Y0109), Trichophyton rubrum (Cmccftla) and Microsporum gypseum (Cmccfmza) ( Table 2) , for in vitro cytotoxic activity against human cancer cell lines, HCT-116 (colon cancer), A549 (lung carcinoma), HeLa (cervical cancer), QGY-7703 (hepatocarcinoma), and MDA231 (breast adenocarcinoma) (Table 3) , and protein tyrosine phosphatase 1B (PTP1B) inhibitory activity (Table 3) . Compounds 1 and 3 showed moderate antifungal activity against the fungus C. neoformans with IC 50 values of 3.67 and 10.85 µg/mL, respectively, while compound 2, bearing an ethyl group at C-8, was inactive even tested at a higher concentration. Compounds 1 and 3 showed weaker antifungal activity towards all the remaining assayed indicators. Furthermore, compound 1 showed moderate cytotoxicity (IC 50 , 11.22 µg/mL) against HeLa cell line, and compound 3 exhibited cytotoxic activity (IC 50 , 9.4 µg/mL) against HCT-116 cell line. Cytotoxicity of compound 3 against A549, HeLa, QGY-7703, and MDA231 cell lines was weaker when compared to that of 1. In addition, compound 3 was tested for PTP1B inhibitory activity in vitro, with an IC 50 value of 4.7 µg/mL. The PTP1B inhibitors are recognized as potential therapeutic agents for the treatment of type II diabetes and obesity [19] . 
Experimental Section

General Experimental Procedures
Optical rotations were determined with a Perkin-Elmer 341 polarimeter with 1 mm cell. IR spectra were recorded on a Bruker vector 22 spectrometer with KBr pellets. The NMR experiments were conducted on Bruker AVANCE-600 and Bruker AMX-500 instruments. HRESIMS and ESIMS were obtained on a Q-Tof micro YA019 mass spectrometer. In antifungal evaluation, IC 50 
Animal Material
Extraction and Isolation
The air-dried and powdered sponge (1.0 kg, dry weight) was extracted with 95% aqueous EtOH, and the combined extracts were concentrated under reduced pressure at 45 °C to yield the crude extract (100 g). This extract was suspended in H 2 O and extracted with EtOAc and n-BuOH to afford the EtOAc-and n-BuOH-soluble extracts. The EtOAc-soluble extract (80 g) was partitioned between 90% aqueous MeOH and n-hexane to afford the n-hexane-soluble extract (21 g), which was subjected to Vacuum Liquid Chromatography (VLC) on silica gel by gradient elution using n-hexane/acetone Preparation of MTPA esters 1a and 1b: Woodylide A (1; 1.2 mg (3.8 μmol) and 1.0 mg (3.2 μmol), respectively) was reacted with R-(−)-or S-(+)-MTPACl (59.4 μmol) in freshly distilled dry pyridine (500 µL) and stirred under N 2 at room temperature for 18 h, respectively, and then the solvent was removed. The products were purified by mini-CC on silica gel (200 mesh, n-hexane:EtOAc, 3:1) to afford S-(−)-and R-(+)-MTPA esters 1a and 1b, respectively.
Preparation of MTPA esters 3a and 3b: Woodylide C (3; 1.2 mg (4.0 μmol) and 1.1 mg (3.7 μmol), respectively) was similarly processed to give S- (−)-and R-(+)-MTPA esters 3a and 3b, 
Antifungal Evaluation
Antifungal IC 50 values of woodylides A-C against C. neoformans were calculated as described by Ikhlas A. Khan et al. [20] . Amphotericin B was used as the positive control. Minimal Inhibition Concentration (MIC) values of woodylides A-C were determined against three indicators (C. albicans, T. rubrum, and M. gypseum), following the National Center for Clinical Laboratory Standards (NCCLS) methods [21, 22] . Fluconazole was used as the positive control. Briefly, samples (dissolved in DMSO) were serially diluted in 20% DMSO/saline and transferred (10 µL 
Cytotoxicity Assay
The cytotoxicity of compounds 1-3 against HCT-116, A549, HeLa, QGY-7703, and MDA231 cell lines was evaluated by the MTT assay as described in a previous report [23] . Briefly, compounds were solubilized in DMSO with the working concentration of test substances ranging from 1 to 100 μg/mL. Cells at the exponential growth phase were harvested and seeded into 96-well plates. After incubation for 24 h, the cells were treated with various concentrations of test substances for 48 h and then incubated with 1 mg/mL MTT at 37 °C for 4 h, followed by dissolving in DMSO. The produced formazan was measured by the absorbance at 570 nm on a microplate reader. The IC 50 values were calculated on the basis of percentage inhibition using the linear regression method.
PTP1B Inhibitory Assay
PTP1B inhibitory activity was determined using a PTP1B inhibitory assay as described previously [24] . The enzymatic activities of the PTP1B catalytic domain were determined at 30 °C by monitoring the hydrolysis of pNPP. Dephosphorylation of pNPP generated the product pNP, which was monitored at an absorbance of 405 nm. In a typical 100 μL assay mixture containing 50 mmol/L 3-[N-morpholino]propanesulfonic acid (MOPs), pH 6.5, 2 mmol/L pNPP, and 30 nmol/L recombinant PTP1B, activities were continuously monitored and the initial rate of the hydrolysis was determined using the early linear region of the enzymatic reaction kinetic curve.
Conclusions
In this paper we report the isolation and the structural determination of three new linear polyketides, woodylides A-C, endowed with antifungal, antineoplastic, and PTP1B inhibitory activities, from the South China Sea marine sponge P. simplex. Unfortunately, due to the lack of compound 2, the absolute configuration at C-3 as well as the bioactivity of woodylide B could not be determined. Woodylide C exhibited a good PTP1B inhibitory activity, and deserves further study for its therapeutic potential against type II diabetes and obesity diseases.
